RxDoctor Payments Data

Anthony Lanfranco, MD

Critical Care Medicine · Philadelphia, PANPI 1780893693

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (40.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 82.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $3,296 and has fallen 56.9% since, to $1,419 in 2025. Among critical care medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,885in general payments, 2019–2025

Across 34 payments — averaging $231.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • Olympus Corporation$548
  • Johnson & Johnson$516
  • Siemens Medical Solutions USA, Inc.$196
  • Galvanize Therapeutics, Inc$100

What the payments were for

  • Consulting fees$5487%
  • Travel & lodging$3,03238%
  • Food & beverage$1,09114%
  • Education$3,21441%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,885 in reported general payments places this provider in the 90th percentile of 354 critical care medicine providers in Pennsylvania.

See all critical care medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$77,210
Medicare patients
263
Services billed
693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$22,878
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr36$18,692
Breo ElliptaFluticasone/Vilanterol22$8,805
Incruse ElliptaUmeclidinium Bromide23$7,105
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$3,948
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$2,400
Albuterol Sulfate HfaAlbuterol Sulfate32$1,154
Proair RespiclickAlbuterol Sulfate13$862
Azithromycin22$418
Prednisone17$59

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →